Ahead of its premiere from June 9–11, 2026, at CityCube Berlin, bio:cap is hosting a Digital Preview on May 6. Media representatives and industry professionals will gain an exclusive first look at the key themes of the new international investival. The focus will be on life sciences and artificial intelligence, new investment dynamics, as well as highlights from the speaker program and selected side events in Berlin.

Leading voices from science, venture capital, and translational medicine – including Prof. Dr. Ariel Dora Stern, Alexander von Humboldt Professor of Digital Health, Economics and Policy at the Hasso Plattner Institute, Dr. Andreas Schmidt, Managing Director at Springboard Health Angels, Prof. Dr. Eicke Latz, Professor of Experimental Rheumatology at Charité – Universitätsmedizin Berlin, as well as Lara Formichella, Project Lead of bio:cap – will share insights into the opportunities and challenges shaping Europe’s next phase in biotechnology and health innovation. Participants will also gain a first look at bio:cap’s high-calibre speaker line-up, selected side events across Berlin, and its distinctive investival format.

The session concludes with a live Q&A, giving participants the opportunity to engage directly with the speakers and gain further insights ahead of bio:cap’s premiere.

Wednesday, 6 May 2026 | 1:00–1:45 PM (CEST)
Digital via livestream
Language: English

iCal (ICS, 57 kB)

Outlook (MSG, 45 kB)

Accreditation for media representatives is now open. Journalists, bloggers, and creators can already register for bio:cap 2026. After successful review, accredited media representatives will receive their confirmation as well as further event information.

Further information on accreditation.

About bio:cap

bio:cap is an investival at the intersection of life sciences and artificial intelligence. The format is aimed at the entire international life science ecosystem and connects capital, technology and research in an open, investment-oriented environment. At bio:cap, leading international investors meet start-ups, research institutions and companies from the fields of biotech, techbio, diagnostics and AI – complemented by decision-makers from the world of politics. bio:cap will take place for the first time from 9 to 11 June 2026 at CityCube Berlin. The event is organised by Messe Berlin in cooperation with Charité – Universitätsmedizin Berlin, the Berlin Institute of Health at Charité (BIH) and the Hasso Plattner Institute (HPI). Handelsblatt is the content and media partner.